{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-111677","form_type":"8-K","ticker":"HSIC","cik":"0001000228","company_name":"HENRY SCHEIN INC","filed_at":"2025-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.111787+00:00","generated_at":"2026-05-22T21:47:23.062820+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Henry Schein appoints KKR partner Max Lin to board; removes KKR voting commitment","bullets":["Max Lin, a KKR partner and head of Americas Health Care Private Equity, appointed to board effective May 2, 2025.","Board size increased to 15 directors; Lin will serve on Nominating/Governance and Strategic Advisory committees.","Regulatory conditions (HSR, Sweden/Italy approvals) for Lin's appointment satisfied as of April 10, 2025.","Lin receives standard non-employee director cash compensation (payable to KKR) but no equity grants.","Letter agreement deletes Section 5.11 of the KKR Strategic Partnership Agreement, removing investor's voting commitment."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-111677","json":"https://secwatch.observer/filing/0001193125-25-111677.json","markdown":"https://secwatch.observer/filing/0001193125-25-111677.md","text":"https://secwatch.observer/filing/0001193125-25-111677.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000228/000119312525111677/0001193125-25-111677-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000228/000119312525111677/d71170d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T21:47:23.062820+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8bdcdc1473","claim":"Max Lin was appointed as Director at HENRY SCHEIN INC.","evidence_excerpt":"On May 2, 2025, Max Lin was appointed to the Company’s board of directors (the “ Board ”) as a director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1000228/000119312525111677/0001193125-25-111677-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}